You would think this will have apositive impact on the share price starting Monday? Even w the possible dilution. If another larger stem cell company thinks there is value in CBAI and puts 200 grand up in the stock, that tells me CBAI is undervalued. Plus the institution that bought some cbai (could still be buying) has 700+ million in assets, they must see something in CBAI
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.